11 October 2018

Nigeria: PSN, GSK Partner On Better Care Delivery

A leading healthcare firm, GlaxoSmithKline (GSK) Pharmaceutical Nigeria Plc., has partnered with the Pharmaceutical Society of Nigeria (PSN) to engender better healthcare delivery as well as recognise pharmacists.

During the event, which held in Lagos, stakeholders appreciated the role of pharmacists in improving healthcare globally and brainstormed on key issues affecting the sector in Nigeria.

GSK's Managing Director, Mr. Bhushan Akshikar, said his organisation sees the partnership as a valuable platform to improve the discipline of pharmacy and celebrate dedicated pharmacists for their contribution to improving the nation's healthcare sector

He added that pharmacists were playing their part in the actualisation of Goal 3 of the Sustainable Development Goals (SDGs) geared at bettering the health and well-being of people.

His words: "For us at GSK, we take great pride as being one of the largest employers of pharmacists in Nigeria with over 160 of them. We have and will continue to support the huge roles pharmacists play in the Nigerian healthcare sector."

PSN's president, Mr Ahmed Yakasai, while thanking the pharmaceutical company for identifying with them, noted that pharmacists needed to be supported to develop the requisite capability and competence for boosting the practice of the profession in the country.

"For the Nigerian healthcare sector to move to the next level, pharmacists must be recognised as medicine experts. They should be rewarded for their significant expertise, skills and training. We also need optimum medicine management. Pharmacists are crucial in the actualisation of this goal," he added.


Campaign Spending By Leading Political Parties May Double 2015 Figures

The election campaigns kicked off about a month ago, and the season is full of prospects, especially for the media… Read more »

See What Everyone is Watching

Copyright © 2018 The Guardian. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.